TECMA SOLUTIONS SPA (TCM.MI) Fundamental Analysis & Valuation

BIT:TCM • IT0005425050

Current stock price

1.65 EUR
-0.31 (-15.82%)
Last:

This TCM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TCM.MI Profitability Analysis

1.1 Basic Checks

  • In the past year TCM has reported negative net income.
  • In the past year TCM had a positive cash flow from operations.
  • TCM had negative earnings in 4 of the past 5 years.
  • In multiple years TCM reported negative operating cash flow during the last 5 years.
TCM.MI Yearly Net Income VS EBIT VS OCF VS FCFTCM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -15.15%, TCM is doing worse than 77.61% of the companies in the same industry.
  • TCM has a Return On Equity of -55.32%. This is in the lower half of the industry: TCM underperforms 77.61% of its industry peers.
Industry RankSector Rank
ROA -15.15%
ROE -55.32%
ROIC N/A
ROA(3y)-31.18%
ROA(5y)-18.32%
ROE(3y)-80.71%
ROE(5y)-47.96%
ROIC(3y)N/A
ROIC(5y)N/A
TCM.MI Yearly ROA, ROE, ROICTCM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • The Gross Margin of TCM (78.63%) is better than 65.67% of its industry peers.
  • In the last couple of years the Gross Margin of TCM has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for TCM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y0.03%
TCM.MI Yearly Profit, Operating, Gross MarginsTCM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. TCM.MI Health Analysis

2.1 Basic Checks

  • TCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TCM has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TCM has more shares outstanding
  • Compared to 1 year ago, TCM has a worse debt to assets ratio.
TCM.MI Yearly Shares OutstandingTCM.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
TCM.MI Yearly Total Debt VS Total AssetsTCM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of 0.19, we must say that TCM is in the distress zone and has some risk of bankruptcy.
  • TCM has a Altman-Z score of 0.19. This is in the lower half of the industry: TCM underperforms 73.13% of its industry peers.
  • The Debt to FCF ratio of TCM is 7.22, which is on the high side as it means it would take TCM, 7.22 years of fcf income to pay off all of its debts.
  • TCM has a better Debt to FCF ratio (7.22) than 77.61% of its industry peers.
  • TCM has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.64, TCM is doing worse than 73.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 7.22
Altman-Z 0.19
ROIC/WACCN/A
WACC6.78%
TCM.MI Yearly LT Debt VS Equity VS FCFTCM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 3.27 indicates that TCM has no problem at all paying its short term obligations.
  • TCM's Current ratio of 3.27 is amongst the best of the industry. TCM outperforms 80.60% of its industry peers.
  • TCM has a Quick Ratio of 3.27. This indicates that TCM is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of TCM (3.27) is better than 85.07% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
TCM.MI Yearly Current Assets VS Current LiabilitesTCM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TCM.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.74% over the past year.
  • TCM shows a decrease in Revenue. In the last year, the revenue decreased by -0.74%.
  • TCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.75% yearly.
EPS 1Y (TTM)61.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)-0.74%
Revenue growth 3Y11.91%
Revenue growth 5Y26.75%
Sales Q2Q%-5.24%

3.2 Future

  • TCM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.50% yearly.
  • The Revenue is expected to decrease by -12.24% on average over the next years. This is quite bad
EPS Next Y32.38%
EPS Next 2Y20.7%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue Next Year2.83%
Revenue Next 2Y-16.37%
Revenue Next 3Y-12.24%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TCM.MI Yearly Revenue VS EstimatesTCM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
TCM.MI Yearly EPS VS EstimatesTCM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

5

4. TCM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TCM. In the last year negative earnings were reported.
  • TCM is valuated cheaply with a Price/Forward Earnings ratio of 7.46.
  • 91.04% of the companies in the same industry are more expensive than TCM, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. TCM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.46
TCM.MI Price Earnings VS Forward Price EarningsTCM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TCM indicates a rather cheap valuation: TCM is cheaper than 89.55% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as TCM.
Industry RankSector Rank
P/FCF 17.38
EV/EBITDA 8.19
TCM.MI Per share dataTCM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TCM's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.7%
EPS Next 3Y13.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TCM.MI Dividend Analysis

5.1 Amount

  • TCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TCM.MI Fundamentals: All Metrics, Ratios and Statistics

TECMA SOLUTIONS SPA

BIT:TCM (2/6/2026, 7:00:00 PM)

1.65

-0.31 (-15.82%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners9.97%
Inst Owner ChangeN/A
Ins Owners43.53%
Ins Owner ChangeN/A
Market Cap14.21M
Revenue(TTM)13.65M
Net Income(TTM)-1.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.46
P/S 1.01
P/FCF 17.38
P/OCF 6.53
P/B 3.96
P/tB 20.35
EV/EBITDA 8.19
EPS(TTM)-0.2
EYN/A
EPS(NY)0.22
Fwd EY13.41%
FCF(TTM)0.09
FCFY5.75%
OCF(TTM)0.25
OCFY15.31%
SpS1.63
BVpS0.42
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.15%
ROE -55.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.63%
FCFM 5.84%
ROA(3y)-31.18%
ROA(5y)-18.32%
ROE(3y)-80.71%
ROE(5y)-47.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y0.03%
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 7.22
Debt/EBITDA 3.16
Cap/Depr 33.82%
Cap/Sales 9.7%
Interest Coverage N/A
Cash Conversion 116.65%
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 0.19
F-Score6
WACC6.78%
ROIC/WACCN/A
Cap/Depr(3y)72.79%
Cap/Depr(5y)132.88%
Cap/Sales(3y)29.58%
Cap/Sales(5y)33.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y32.38%
EPS Next 2Y20.7%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.74%
Revenue growth 3Y11.91%
Revenue growth 5Y26.75%
Sales Q2Q%-5.24%
Revenue Next Year2.83%
Revenue Next 2Y-16.37%
Revenue Next 3Y-12.24%
Revenue Next 5YN/A
EBIT growth 1Y71.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.87%
EBIT Next 3Y32.93%
EBIT Next 5YN/A
FCF growth 1Y116.97%
FCF growth 3YN/A
FCF growth 5Y22.2%
OCF growth 1Y179.97%
OCF growth 3YN/A
OCF growth 5Y33.66%

TECMA SOLUTIONS SPA / TCM.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TECMA SOLUTIONS SPA (TCM.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TCM.MI.


What is the valuation status for TCM stock?

ChartMill assigns a valuation rating of 5 / 10 to TECMA SOLUTIONS SPA (TCM.MI). This can be considered as Fairly Valued.


How profitable is TECMA SOLUTIONS SPA (TCM.MI) stock?

TECMA SOLUTIONS SPA (TCM.MI) has a profitability rating of 1 / 10.


How financially healthy is TECMA SOLUTIONS SPA?

The financial health rating of TECMA SOLUTIONS SPA (TCM.MI) is 4 / 10.